Skip to main content

Myron Cohen

Myron Cohen, MD, is a UNC Lineberger Comprehensive Cancer Center member researching the biology and epidemiology of sexually transmitted diseases, including human immunodeficiency virus (HIV) and Zika.

MD
Yeargan-Bate Distinguished Professor of Medicine, Microbiology and Immunology
Professor, Epidemiology
UNC Gillings School of Global Public Health
Associate Vice Chancellor for Global Health and Medical Affairs
Director, Institute for Global Health & Infectious Diseases
UNC-Chapel Hill
Clinical Research

Area of Interest

Biology and epidemiology of sexually transmitted diseases, including human immunodeficiency virus (HIV) and Zika

Myron Cohen, MD, works in clinical research, clinical trials, translational research and basic science research. He is an infectious disease specialist widely known for his work on transmission and prevention of transmission of HIV. His work has focused on HIV prevention and has involved clinical research, global research, and use of the tools of epidemiology, virology and pharmacology. Cohen helped to develop laboratory methods to measure HIV in genital secretions, as well as methods to determine the best antiviral agents to reduce replication of HIV in these compartments.

Cohen is the architect and principal investigator of the multinational HIV Prevention Trials Network (HPTN) 052 study, which demonstrated that antiretroviral treatment prevents the sexual transmission of HIV-1. This work was recognized by Science Magazine as the “Breakthrough of the Year” in 2011.

Awards and Honors

  • North Carolina Award for Science, State of North Carolina, 2013
  • Joseph E. Smadel Lectureship Award, Infectious Diseases Society of America, 2013
  • O. Max Gardner Award for Medicine, Microbiology & Public Health, UNC-Chapel Hill, 2008
  • Distinguished Career Award Lifetime Achievement in STD/HIV Research, American Sexually Transmitted Diseases Association, 2005

Find publications on PubMed